மரியோ நெக்ரி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மரியோ நெக்ரி நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மரியோ நெக்ரி நிறுவனம் Today - Breaking & Trending Today

"EU Hard Lockdowns are Crimes against Humanity". Italian Magistrate's Complaint to Hague Court – Veterans Today | Military Foreign Affairs Policy Journal for Clandestine Services


«Lockdown and all-related measures – the latter if adopted for prolonged and indefinite periods of time, well beyond the health emergency phase, so as to risk distorting the very essence of societies, and this is the case – are a crime against humanity as they constitute the crimes of imprisonment, torture and are acts causing great suffering to mental and physical health (section 7 of the Rome Statute)».
This is one of the most disruptive sentences of the explosive complaint signed by the Italian magistrate Angelo Giorgianni and sent yesterday, Wednesday 24 March, to the Prosecutor of the International Criminal Court (ICC) Ms Fatou Bensouda. ....

Schleswig Holstein , New York , United States , Italy General , United Kingdom , South Africa , Sri Lanka , Great Britain , Giorgio Pal , Fatou Bensouda , Stefan Swartling Peterson , Mario Draghi , Angelo Giorgianni , Anna Mia Ekstr , Roberto Speranza , Giuseppe Conte , Fabio Giuseppe Carlo Carisio , Reiner Fuellmich , Stefano Vicari , David Nabarro , Alessandro Meluzzi , Maria Van Kerkhove , Bill Gates , Roberta Ricciardi , Robert Redfield , Francesco Zambon ,

Press review: Why Hezbollah visited Moscow and Sputnik V jab likely to enter EU market


Top stories in the Russian press on Tuesday, March 16
Head of Hezbollah s parliamentary bloc Mohammad Raad and Russian Foreign Minister Sergey Lavrov© The Russian Foreign Ministry s press office/TASS
 
Izvestia: Russia’s Sputnik V likely to enter EU market
Russia is working with its European partners to expand the production of the Sputnik V coronavirus vaccine, head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said in a statement. According to him, the RDIF has already reached agreements with companies from Italy, Spain, France and Germany, which will make it possible to start vaccine supplies to the European market once the EU medical regulator approves the Russian medication. ....

Gorod Astana , Gabi Ashkenazi , Anton Mardasov , Sergey Lavrov , Ivan Vilibor Sincic , Forschungsgruppe Wahlen , Bashar Al Assad , Mohammad Raad , Russia Ministry Of Digital Development , Christian Social Union In Bavaria , European Parliament Committee On Environment , Democratic Party , Moscow State University , German Studies Center , Syrian Constitutional Committee , Christian Democratic Union , Nezavisimaya Gazeta , Public Health , Russian International Affairs Council , European Medicines Agency , Germany Christian Democratic Union , Institute For Parliamentary Research Benjamin Hohne , Mario Negri Institute , Pharmacological Research Antonio Clavenna , European Parliament , Food Safety ,

Another Weight-Loss Trial Win for Weekly GLP-1 Drug


email article
When paired with lifestyle management, once-weekly semaglutide (Ozempic) yielded significant weight loss for overweight adults with type 2 diabetes, the manufacturer-sponsored Semaglutide Treatment Effect in People with Obesity (STEP) 2 study found.
In the superiority phase III trial of over 1,200 adults with a body mass index (BMI) of at least 27, those on 2.4 mg of weekly subcutaneous semaglutide lost an average of 9.6% of baseline body weight after 68 weeks of treatment versus 3.4% for those on placebo and lifestyle intervention alone (treatment difference -6.2 percentage points, 95% CI -7.3 to -5.2,
P 0.0001), reported Ildiko Lingvay, MD, of the University of Texas Southwestern Medical Center in Dallas, and colleagues. ....

New York , United States , South Africa , Roberto Latini , Pliraglutide Saxenda , Lidia Staszewsky , Mario Negri Institute Of Pharmacological Research , Novo Nordisk , Semaglutide Treatment Effect , Mario Negri Institute , Pharmacological Research , North America , South America , Middle East , New York City , Weight Decreased , Diabetes Mellitus Type 2 , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ரொபெர்டோ லத்தினி , மரியோ நெக்ரி நிறுவனம் ஆஃப் மருந்தியல் ஆராய்ச்சி , மரியோ நெக்ரி நிறுவனம் , மருந்தியல் ஆராய்ச்சி , வடக்கு அமெரிக்கா , தெற்கு அமெரிக்கா , நடுத்தர கிழக்கு ,